ALEXANDRIA, Va., April 7 -- United States Patent no. 12,595,473, issued on April 7, was assigned to ROQUETTE FRERES (Lestrem, France).
"Genetically modified bacillus subtilis strain, optimized vectors, and uses thereof" was invented by Sebastien Maubourguet (Lompret, France), Sophie Huchette (Betbune, France), Claudia Borgmeier (Bensheim, Germany) and Guido Meurer (Seeheim-Jugenheim, Germany).
According to the abstract* released by the U.S. Patent & Trademark Office: "A genetically modified Bacillus subtilis strain has been transformed with an optimized vector, mainly for producing a D-psicose 3-epimerase."
The patent was filed on March 22, 2024, under Application No. 18/613,291.
*For further information, including images, charts and ta...